Showing Page 2 of 9
FDA Approves Additional Doses of Trulicity® (dulaglutide) for the Treatment of Type 2 Diabetes / OSP News
The AWARD-11 trial showed 3.0 mg and 4.5 mg doses of dulaglutide led to additional blood sugar control and as a secondary endpoint, both doses also led to weight loss.
Blue Cross Completes Prior Authorization Reduction Notification - Revised / Health Plan News
Blue Cross Complete has removed the prior authorization requirements for a select set of procedure codes and changed the requirements for others.
Blue Care Network (BCN) and Blue Cross Blue Shield's (BCBS) Monthly Blues Brief for September 2020 / Health Plan News
Blue Care Network (BCN) and Blue Cross Blue Shield's (BCBS) Monthly Blues Brief for September 2020.
Blue Cross Completed wanted to Inform You: MDHHS COVID-19 Response: Recession of Portions of Bulletin MSA 20-28 / Health Plan News
The Michigan Department of Health and Human Services issued a Bulletin to rescind portions of Bulletin MSA 20-28 that are specific to provisions of Executive Order 2020-61.
Vaccines During COVID / OSP News
Even during these difficult times, it is still important to outreach to patients and families emphasizing the need to stay current with routine vaccinations.
Meridian Health Plan Education Handout for August 2020 / Health Plan News
Meridian Health Plan Education Handout for August 2020.
MDHHS Announces $25 million for Personal Protective Equipment to Keep Frontline Workers and Patients Safe from COVID-19 / OSP News
The grant will assist facilities facing increased costs for PPE as they provide critical services to Michiganders during the COVID-19 pandemic.
The MDHHS announced, the U.S. Department of Health and Human Services, released information on additional funds targeted to Medicaid and Children’s Health Insurance Programs through the Provider Relief Fund as a part of the CARES Act.
HAP Updates for August 2020 / Health Plan News
HAP Updates for August 2020.
Meridian: TurningPoint Medicaid Notification / Health Plan News
Meridian is pleased to announce the expansion of our Surgical Quality and Safety Management Program with TurningPoint Healthcare Solutions, LLC., to now include Medicaid members.
Blue Cross Complete Emergency Services Level of Care Review Policy / Health Plan News
All claim diagnoses will be considered for determination of consistency with the Level 4 or 5 ED E&M service that was billed.
McLaren Updates for August 2020 / Health Plan News
McLaren Updates for August 2020.
Priority Health Will Be Offering Electronic Pharmacy Prior Authorization’s / Health Plan News
Starting August 31, 2020, you’ll have the option to submit pharmacy prior authorizations for Priority Health members electronically.
Michigan Department of Health and Human Services (MDHHS) Updates for Food Assistance, Phone Assistance and Recent MI Bridge Updates / OSP News
Due to the Governor’s State of Emergency being extended, they are extending the guidance for providing assistance to clients over the phone.
Molina Announces: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents (WCC) / Health Plan News
This measure demonstrates the percentage of members age 3-17, who had an outpatient/office visit with a primary care practitioner (PCP) or OB/GYN, and who had evidence of the following during the measurement year.
HAP Updates July 2020 / Health Plan News
HAP Updates July 2020.
Blue Cross Complete Modifier 25 and MTR Reduction Policy Updates / Health Plan News
Effective September 1, 2020, Blue Cross Complete will implement two policy updates.
Total Health Care Updates for July 2020 / Health Plan News
Total Health Care Updates for July 2020.
Blue Cross Complete (BCC) of Michigan July/August 2020 Complete Update / Health Plan News
Blue Cross Complete (BCC) of Michigan July/August 2020 Complete Update.
Drug Recall: Metformin ER Products From Certain Manufacturers / Health Plan News
The U.S. Food and Drug Administration (FDA) recently requested that prescription metformin ER products manufactured by Apotex Inc., Amneal Pharmaceutics, Granules Pharmaceuticals and Lupin Pharmaceuticals be removed from the market.